US Stock MarketDetailed Quotes

ARCT Arcturus Therapeutics

Watchlist
  • 16.060
  • -0.630-3.77%
Close Feb 25 16:00 ET
  • 16.060
  • 0.0000.00%
Post 20:01 ET
435.02MMarket Cap-6.89P/E (TTM)

About Arcturus Therapeutics Company

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Company Profile

SymbolARCT
Company NameArcturus Therapeutics
Listing DateMay 22, 2013
Founded2013
CEOMr. Joseph E. Payne
MarketNASDAQ
Employees180
Fiscal Year Ends12-31
Address10628 Science Center Drive,Suite 250
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-900-2660

Company Executives

  • Name
  • Position
  • Salary
  • Joseph E. Payne
  • Director, President and Chief Executive Officer
  • 4.89M
  • Andrew H. Sassine
  • Director and Chief Financial Officer
  • 2.18M
  • Lance Kurata
  • Chief Legal Officer
  • 2.10M
  • Dr. Padmanabh Chivukula
  • Chief Scientific Officer and Chief Operating Officer
  • 3.18M
  • Dr. Peter C. Farrell, A.M.,PhD
  • Chairman of the Board
  • 328.00K
  • Dr. Moncef M. Slaoui, PhD
  • Independent Director
  • --
  • Dr. John H. Markels, PhD
  • Independent Director
  • 320.50K
  • Dr. Edward W. Holmes
  • Independent Director
  • 325.50K
  • James F. Barlow
  • Independent Director
  • 330.50K
  • Dr. Magda Marquet, PhD
  • Independent Director
  • 318.00K
  • Dr. Jing L. Marantz, M.D.,PhD
  • Independent Director
  • 318.00K
  • Joseph Robert
  • Controller
  • --

Trending Stocks

Discussing
Widespread uptick! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. Show More